一种用于肾移植中移植肾功能延迟的无钙调神经磷酸酶拮抗剂诱导免疫抑制策略。 - Suppr | 超能文献

A calcineurin antagonist-free induction immunosuppression strategy for delayed graft function in renal transplantation.

作者信息

Hong J C, Kahan B D

机构信息

Division of Immunology and Organ Transplantation, University of Texas-Houston, Houston, Texas, USA.

出版信息

Transplant Proc. 2001 Feb-Mar;33(1-2):1271-2. doi: 10.1016/s0041-1345(00)02474-x.

DOI:10.1016/s0041-1345(00)02474-x

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

A calcineurin antagonist-free induction immunosuppression strategy for delayed graft function in renal transplantation.一种用于肾移植中移植肾功能延迟的无钙调神经磷酸酶拮抗剂诱导免疫抑制策略。

Transplant Proc. 2001 Feb-Mar;33(1-2):1271-2. doi: 10.1016/s0041-1345(00)02474-x.

2

A calcineurin antagonist-free induction strategy for immunosuppression in cadaveric kidney transplant recipients at risk for delayed graft function.

Transplantation. 2001 May 15;71(9):1320-8. doi: 10.1097/00007890-200105150-00025.

3

The role of newer monoclonal antibodies in renal transplantation.新型单克隆抗体在肾移植中的作用。

Transplant Proc. 2001 Feb-Mar;33(1-2):1000-1. doi: 10.1016/s0041-1345(00)02303-4.

4

Balancing efficacy and toxicity in kidney-transplant immunosuppression.肾移植免疫抑制中疗效与毒性的平衡

N Engl J Med. 2007 Dec 20;357(25):2625-7. doi: 10.1056/NEJMe078181.

5

Long-term follow-up after induction treatment with monoclonal anti-interleukin-2 receptor antibody (BT563) in kidney allograft recipients: a double-blind, placebo-controlled trial.肾移植受者接受单克隆抗白细胞介素-2受体抗体（BT563）诱导治疗后的长期随访：一项双盲、安慰剂对照试验。

Transplant Proc. 1996 Dec;28(6):3221-2.

6

BTI-322 for induction therapy after renal transplantation: a randomized study.肾移植后诱导治疗使用BTI-322：一项随机研究。

Transplant Proc. 1997 Feb-Mar;29(1-2):317-9. doi: 10.1016/s0041-1345(96)00282-5.

7

Effect of low-dose calcineurin inhibitors on acute rejection and graft survival.

Transplant Proc. 2002 Sep;34(6):2079-80. doi: 10.1016/s0041-1345(02)02858-0.

8

Randomized trial of three different immunosuppressive regimens to prevent chronic renal allograft rejection.三种不同免疫抑制方案预防慢性肾移植排斥反应的随机试验

Transplant Proc. 2002 Aug;34(5):1610-1. doi: 10.1016/s0041-1345(02)03042-7.

9

Sequential quadruple immunosuppression including sirolimus in extended criteria and nonheartbeating donor kidney transplantation.序贯四联免疫抑制，包括西罗莫司在扩大标准供体和非心脏死亡供体肾移植中的应用。

Transplantation. 2007 Aug 15;84(3):429-32. doi: 10.1097/01.tp.0000269610.13590.52.

10

Rapamycin use and rapid withdrawal of calcineurin inhibitors in pediatric renal transplantation.雷帕霉素在小儿肾移植中的应用及钙调神经磷酸酶抑制剂的快速撤减

Transplant Proc. 2003 Mar;35(2):703-4. doi: 10.1016/s0041-1345(03)00055-1.

引用本文的文献

1

Clinical pharmacokinetics of sirolimus.西罗莫司的临床药代动力学

Clin Pharmacokinet. 2001;40(8):573-85. doi: 10.2165/00003088-200140080-00002.